Podcast

Survivor, Advocate Addresses Disparities in Cancer Care

Author(s):

Kristie L. Kahl

In this episode of the “CURE Talks Cancer” podcast, we spoke with Rose Gerber, a breast cancer survivor and advocate, about disparities in cancer care, in particular in breast cancer.

In this special edition, CURE spoke with Rose Gerber, Director of Patient Advocacy & Education at the Community Oncology Alliance and a breast cancer survivor, about disparities in cancer care, and what we can do to address them moving forward.

CURE® is now accepting nominations for our inaugural Metastatic Breast Cancer Heroes™ Awards! For our inaugural celebration, we are proud to present two separate awards honoring heroes who have made a significant impact in the lives of those affected by metastatic breast cancer. For more information or to nominate your hero today, visit, https://www.curetoday.com/award-events.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
a man and a woman in front of a dark blue background
Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston, and the editor-in-chief of CURE®.
Image of woman with blonde hair.
Image of a woman with wavy blonde hair wearing glasses.
Image of a woman wearing a red tank top.
Image of Annie Bond.
Expert on TNBC, with patient
Related Content
Image of woman with pink robbon.
March 11th 2025

Vepdegestrant May Reduce Disease Progression in Breast Cancer Subset

Spencer Feldman
Vepdegestrant improved progression-free survival in patients with estrogen receptor 1 mutations in advanced ER-positive, HER2-negative breast cancer.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Image of woman.
February 27th 2025

Metronomic Capecitabine and an AI Improve Survival in HR+/HER2– Metastatic Breast Cancer

Ryan Scott
Metronomic capecitabine plus an aromatase inhibitor improved survival outcomes in hormone receptor-positive, HER2-negative metastatic breast cancer.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Illustration of woman with light brown hair.
February 14th 2025

Are We at Risk of Losing Our Breast Cancer Community?

Martha Carlson
I found community after my metastatic breast cancer diagnosis, but recent discord in cancer support groups makes me fear we're losing these vital connections.
FDA Approved Image.
February 3rd 2025

Breaking Down Cancer Therapies Approved by the FDA in January 2025

Ryan Scott
Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations like AML, MDS and breast cancer.